Thank you to all of you for voting for me – your support has put this blog on the national radar …….The best Public Health Blog in Kenya. I could not have done it without your vote. Forever grateful! I am taking some time out with family – will be back soon.
Author Archives: Tabs
A big thank you to all of you who have enjoyed this blog and faithfully kept me company with your comments and encouragement. I would like to see the blog having more influence as a source of evidence-based health research coverage. One of the ways you would help me do this is to push my vote count so that this blog is known as the best public health blog in the country or even the best blog. To do this,
Health journalism is growing in importance – building strong bridges between the media and health researchers has never been more urgent.
The national roll out of HIV PrEP by Kenyan Ministry of Health was yesterday. Groups at risk of HIV acquisition are the main target – on the list is young girls. I had a conversation with Dr Kimani, a researcher on PrEP use – to provide facts about this intervention
‘Sharenting’ is the term that has been coined to describe the way in which parents share details of their children’s lives online. Whereas we fret about empowering children to be safe online – parents are sharing too much detail about their children online.
Over 1,000 women die each year in Kenya due to bleeding after childbirth, over 300 of these women would live if Tranexamic acid was used within 3 hours from when bleeding starts. It’s not a magic bullet – but it is extremely useful.
Treated bednets are crucial in the malaria control arsenal – if people are scared by untruths – deaths will go up.
The malaria vaccine RTS,S will be complementary to other malaria interventions and is not a magic bullet. The time has come for different combinations of approaches to be tried out in different settings and the evidence used to come up with regional plans.
The vaccines that most people are used to: polio, measles, tetanus – prevent over 90% of the disease they protect against – this protection lasts a lifetime. The malaria vaccine RTS,S in trial conditions has been shown to have an efficacy of 26-36% and this efficacy declined quickly.
Tomorrow is world malaria day – having spent a good part of my adult life studying malaria – I am always bursting to talk endlessly about it. However I will restrict myself and talk about the issue of malaria eradication in two short blogs – today and tomorrow.